Conference Coverage

Newcomer canagliflozin improves beta-cell function in type 2 diabetes

Publish date: May 6, 2013

 

AT THE AACE ANNUAL MEETING

On Twitter @NaseemSMiller

Pages

Recommended Reading

Celiac disease patients protected from type 2 diabetes
MDedge Endocrinology
Diabetes treatment algorithm sets goals, time limits
MDedge Endocrinology
Cognitive monitoring urged in type 2 diabetes
MDedge Endocrinology
Six questions flag risk for cardiovascular hospitalization
MDedge Endocrinology
The diabetic foot: Intervene for vascular disease
MDedge Endocrinology
More diabetes educators are needed
MDedge Endocrinology
One in five U.S. adults meets exercise guidelines
MDedge Endocrinology
Diabetes 'cure' holds up 6 years after bariatric surgery
MDedge Endocrinology
Mediterranean diet: No glycemic advantage, but sound dietary approach
MDedge Endocrinology
Hypoglycemia associated with daily variation in blood glucose
MDedge Endocrinology

Related Articles